Creo Medical Limited
CREO.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -87% | 13.4% | 8% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 47.5% | 49.7% | 36.8% | 35.9% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -652.5% | -67.2% | -101.6% | -109.5% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -717.5% | -70.5% | -99.1% | -97.8% |
| EPS Diluted | -0.079 | -0.069 | -0.14 | -0.14 |
| % Growth | -14.6% | 50.5% | 0% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |